Friday, June 3, 2016

BRIEF-Lilly says announces results from Monarch 1 trial of Abemaciclib monotherapy

* Says safety and toxicity profile continuously dosed

Abemaciclib was consistent with previous Phase 1 experience

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)